Jean-Simon Diallo

Center for Innovative Cancer Research, Ottawa Hospital Research Institute (OHRI)

Affiliated withOttawa Hospital Research Institute (OHRI)Ottawa Hospital Research Institute University of Ottawa

Research Area

Biography

Jean-Simon Diallo has not added Biography.
If you are Jean-Simon Diallo and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 22	2011
Publication title Cited by 14	2014

Other Publications

Article	Year
Expression and nuclear localization of ErbB3 in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16675564	2006
An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines. The Prostate\| PubMed ID: 16705740	2006
Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Molecular cancer research : MCR\| PubMed ID: 17259348	2007
NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells. Cellular signalling\| PubMed ID: 17292587	2007
Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer. BJU international\| PubMed ID: 17532856	2007
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18056181	2007
Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis. BJU international\| PubMed ID: 18294307	2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18815361	2008
Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. The Prostate\| PubMed ID: 19170126	2009
Intelligent design: combination therapy with oncolytic viruses. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 20029399	2010
Synergistic interaction between oncolytic viruses augments tumor killing. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 20234341	2010
A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 20389287	2010
A novel method of cell embedding for tissue microarrays. Histopathology\| PubMed ID: 20716176	2010
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. PloS one\| PubMed ID: 21283510	2010
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 21772252	2011
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature\| PubMed ID: 21886163	2011
Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21948474	2012
The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22186794	2011